The mission of GICP program is to understand the pathogenesis and pathophysiology of GI cancers, identify and validate new diagnostic and prognostic tools, and develop new therapeutic options for patients with GI malignancies. To address this mission, the GICP has been organized into three themes.
- The goal of Theme 1 is to understand basic mechanisms of GI tumorigenesis and identify abnormalities that may serve as novel biomarkers or therapeutic targets.
- Theme 2 is focused on developing and validating biomarkers for GI cancer detection, prognosis, and risk stratification.
- Theme 3 explores novel treatment approaches in preclinical models and clinical trials.
Program members are broadly distributed across 7 UNMC departments and have multidisciplinary interests in GI cancer, with particular strength in pancreatic and colon cancer research.
Jennifer Black, Ph.D.
|||Sarah Thayer, M.D., Ph.D.
Professor & Division Chief, Surgical Oncology
Physician-in-Chief, Fred & Pamela Buffett Cancer Center